Literature DB >> 30256458

In memoriam: Fine-needle aspiration, birth: Fine-needle biopsy: The changing trend in endoscopic ultrasound-guided tissue acquisition.

Ji Young Bang1, Sachin Kirtane1, Konrad Krall1, Udayakumar Navaneethan1, Muhammad Hasan1, Robert Hawes1, Shyam Varadarajulu1.   

Abstract

BACKGROUND AND AIM: Fine-needle aspiration (FNA) cytology has been the preferred technique for procuring tissue at endoscopic ultrasound (EUS) procedures for the past 25 years. To overcome some of the limitations of FNA cytology, fine-needle biopsy (FNB) has been recently developed to yield histological tissue. Main objective was to compare the diagnostic yield of FNB compared to FNA for both onsite and offsite specimen assessment.
METHODS: A retrospective study was conducted at a single tertiary referral center to evaluate the outcomes of FNA and FNB over a 4-year period. EUS-guided tissue sampling was carried out using 22- or 25-G FNA needles from 2014 to 2015, and 22-G FNB needle was used from 2016 to 2017.
RESULTS: Of 3020 patients undergoing EUS-guided sampling of solid mass lesions (pancreatic masses 71.3%, other lesions 28.7%), FNA was carried out in 68.9% and FNB in 31.1%. Median number of passes required for diagnostic adequacy on rapid onsite evaluation was significantly lower for FNB compared to FNA (1 [IQR: 1-2] vs 2 [IQR 1-3], P < 0.001). Diagnostic yield on cell block was also significantly superior with FNB compared to FNA (92.3 vs 71.1%, P < 0.001). The superior performance of FNB over FNA was observed for both pancreatic (P < 0.001) and non-pancreatic lesions (P < 0.001).
CONCLUSION: Given these promising findings, in the future, EUS-guided FNB will likely be the preferred technique for sampling of solid mass lesions.
© 2018 Japan Gastroenterological Endoscopy Society.

Entities:  

Keywords:  EUS-guided tissue acquisition; diagnostic yield; fine-needle aspiration; fine-needle biopsy; solid mass lesion

Mesh:

Year:  2018        PMID: 30256458     DOI: 10.1111/den.13280

Source DB:  PubMed          Journal:  Dig Endosc        ISSN: 0915-5635            Impact factor:   7.559


  19 in total

1.  EUS-guided fine-needle biopsy sampling versus FNA in the diagnosis of subepithelial lesions: a large multicenter study.

Authors:  Diogo T H de Moura; Thomas R McCarty; Pichamol Jirapinyo; Igor B Ribeiro; Victor K Flumignan; Fedaa Najdawai; Marvin Ryou; Linda S Lee; Christopher C Thompson
Journal:  Gastrointest Endosc       Date:  2020-02-25       Impact factor: 9.427

Review 2.  The Impact of Recent Advances in Endoscopic Ultrasound-Guided Tissue Acquisition on the Management of Pancreatic Cancer.

Authors:  Susana Marques; Miguel Bispo; Ricardo Rio-Tinto; Paulo Fidalgo; Jacques Devière
Journal:  GE Port J Gastroenterol       Date:  2020-10-23

Review 3.  The Role of Endoscopic Ultrasound in Pancreatic Cancer Staging in the Era of Neoadjuvant Therapy and Personalised Medicine.

Authors:  Miguel Bispo; Susana Marques; Ricardo Rio-Tinto; Paulo Fidalgo; Jacques Devière
Journal:  GE Port J Gastroenterol       Date:  2020-09-07

4.  Diagnostic performance of endoscopic ultrasound-guided tissue acquisition by EUS-FNA versus EUS-FNB for solid pancreatic mass without ROSE: a retrospective study.

Authors:  Thanawin Wong; Tanawat Pattarapuntakul; Nisa Netinatsunton; Bancha Ovartlarnporn; Jaksin Sottisuporn; Naichaya Chamroonkul; Pimsiri Sripongpun; Sawangpong Jandee; Apichat Kaewdech; Siriboon Attasaranya; Teerha Piratvisuth
Journal:  World J Surg Oncol       Date:  2022-06-24       Impact factor: 3.253

5.  Diagnostic yield of Franseen and Fork-Tip biopsy needles for endoscopic ultrasound-guided tissue acquisition: a meta-analysis.

Authors:  Antonio Facciorusso; Valentina Del Prete; Vincenzo Rosario Buccino; Purvi Purohit; Puneet Setia; Nicola Muscatiello
Journal:  Endosc Int Open       Date:  2019-10-01

6.  Evaluation of endoscopic ultrasound fine-needle aspiration versus fine-needle biopsy and impact of rapid on-site evaluation for pancreatic masses.

Authors:  Diogo T H de Moura; Thomas R McCarty; Pichamol Jirapinyo; Igor B Ribeiro; Kelly E Hathorn; Antonio Coutinho Madruga-Neto; Linda S Lee; Christopher C Thompson
Journal:  Endosc Int Open       Date:  2020-05-25

Review 7.  What should be known prior to performing EUS exams? (Part II).

Authors:  Christoph F Dietrich; Paolo Giorgio Arcidiacono; Barbara Braden; Sean Burmeister; Silvia Carrara; Xinwu Cui; Milena Di Leo; Yi Dong; Pietro Fusaroli; Uwe Gottschalk; Andrew J Healey; Michael Hocke; Stephan Hollerbach; Julio Iglesias Garcia; André Ignee; Christian Jürgensen; Michel Kahaleh; Masayuki Kitano; Rastislav Kunda; Alberto Larghi; Kathleen Möller; Bertrand Napoleon; Kofi W Oppong; Maria Chiara Petrone; Adrian Saftoiu; Rajesh Puri; Anand V Sahai; Erwin Santo; Malay Sharma; Assaad Soweid; Siyu Sun; Anthony Yuen Bun Teoh; Peter Vilmann; Hans Seifert; Christian Jenssen
Journal:  Endosc Ultrasound       Date:  2019 Nov-Dec       Impact factor: 5.628

Review 8.  Endoscopic Ultrasound-Guided Fine Needle Aspiration and Endoscopic Retrograde Cholangiopancreatography-Based Tissue Sampling in Suspected Malignant Biliary Strictures: A Meta-Analysis of Same-Session Procedures.

Authors:  Diogo Turiani Hourneax de Moura; Marvin Ryou; Eduardo Guimarães Hourneaux de Moura; Igor Braga Ribeiro; Wanderlei Marques Bernardo; Christopher C Thompson
Journal:  Clin Endosc       Date:  2019-11-05

9.  Comparative diagnostic accuracy of EUS needles in solid pancreatic masses: a network meta-analysis.

Authors:  Samuel Han; Furqan Bhullar; Omar Alaber; Ayesha Kamal; Puanani Hopson; Kavin Kanthasamy; Sarah Coughlin; Livia Archibugi; Nikhil Thiruvengadam; Christopher Moreau; David Jin; Pedram Paragomi; Francisco Valverde-López; Sajan Nagpal; Cemal Yazici; Georgios Papchristou; Peter J Lee; Venkata Akshintala
Journal:  Endosc Int Open       Date:  2021-05-27

Review 10.  Resectable pancreatic solid lesions: Time to move from surgical diagnosis?

Authors:  Alberto Larghi; Mihai Rimbaş; Gianenrico Rizzatti; Giuseppe Quero; Antonio Gasbarrini; Guido Costamagna; Sergio Alfieri
Journal:  Endosc Ultrasound       Date:  2020 Mar-Apr       Impact factor: 5.628

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.